Live Breaking News & Updates on Biotronik

Stay updated with breaking news from Biotronik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biotronik's Passeo-18 Lux Paclitaxel DCB Studied in Subgroup Analyses of BIOPACT RCT

July 13, 2023—Biotronik announced the 1-year subgroup results from the investigator-initiated BIOPACT randomized controlled trial (RCT) evaluati ....

United States , France General , Koen Deloose , Pact Admiral , Leipzig Interventional Course , Vascular Surgery , Blasius Hospital , Paris Vascular Insights , Asseo 18 Lux , Drug Coated Balloon , Iopact Rct ,

BIOTRONIK Demonstrates Ongoing Commitment to Advancing Scientific Knowledge at HRS

/PRNewswire/ Continuing a history of commitment to furthering research in its field, four studies supported by BIOTRONIK s real-world evidence generating. ....

New York , United States , Abhishek Deshmukh , Krishna Pundi , David Hayes , Albert Einstein College Of Medicine New York , Biotronik Inc , Heart Rhythm , Stanford Medicine , Natural Experiment , Air Pollution , Ventricular Arrhythmias , Physical Activity , Mayo Clinic , Luigi Di Biase , Albert Einstein College , Chief Medical Officer ,

LATE-BREAKING TRIAL PRESENTED AT HRS SHOWS MEASURABLE DIFFERENCE IN OUTCOMES BETWEEN PATIENTS BY SEX

/PRNewswire/ Data presented at Heart Rhythm Society s 2023 Conference show a measurable difference in outcomes between male and female patients when looking. ....

United States , Amy Culley , Jeanne Poole , Valentina Kutyifa , University Of Rochester Data Coordinating Center , Heart Rhythm Society , Biotronik Inc , Rochester Data Coordinating Center , Clinical Studies , Non Ischemic Cardiomyopathy Patients , Implanted Defibrillator , Cardiac Resynchronization Therapy , New Orleans , Ventricular Arrhythmias , Non Ischemic Cardiomyopathy ,

INSIGHT-Medical device makers drop products as EU law sows chaos

Just as painful is the fact Osypka cannot afford costs estimated at one million euros ($1.1 million) to prepare the application for an innovative product that has already been through clinical trials. The company's new stent for babies was developed over eight years and doctors successfully used it on 19 babies during the trial in Germany, according to the results seen by Reuters. ....

Region Flamande , Bruxelles Capitale , Frank Matzek , Nicola Osypka , Marc Gewillig , Tom Melvin , Mikael Johansson , Andreas Kohl , John Odea , European Council , Eu Health , University Hospital Leuven , Eu Commission , Drug Administration , Trinity College Dublin , Standing Committee Of European Doctors , European Union , Poly Implant Prothese , Devices Regulation , Standing Committee , European Doctors , Johno Dea , Andreas Kohl , The Eu Commission , Icola Osypka 39 S , Trinity College Dublin ,

BIOTRONIK Enrolls First Patient Into BIO-CONDUCT, First IDE Trial to Study Use of Stylet-Driven Leads for Conduction System Pacing

/PRNewswire/ BIOTRONIK, a global leader in the treatment of cardiac and vascular disease is pleased to announce the first patient enrollment in BIO-CONDUCT,. ....

United States , Larry Chinitz , David Hayes , Langone Heart Rhythm Center , Heart Rhythm Center , Cardiac Electrophysiology , Chief Medical Officer ,